Clinical Application of Botulinum Toxin for Hemifacial Spasm
Hemifacial spasm is typically caused by contact between the facial nerve and blood vessels. Microvascular decompression, a treatment that directly addresses this pathogenesis, is often considered the most effective treatment method. However, surgery is not immediately performed for patients at risk...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/13/8/1760 |
| _version_ | 1797584046753054720 |
|---|---|
| author | Chang-Kyu Park Seung-Hoon Lim Kwan Park |
| author_facet | Chang-Kyu Park Seung-Hoon Lim Kwan Park |
| author_sort | Chang-Kyu Park |
| collection | DOAJ |
| description | Hemifacial spasm is typically caused by contact between the facial nerve and blood vessels. Microvascular decompression, a treatment that directly addresses this pathogenesis, is often considered the most effective treatment method. However, surgery is not immediately performed for patients at risk from the surgical treatment, or for those with an unclear diagnosis. In these instances, Botulinum toxin injection can help manage the patient’s symptoms. Numerous studies corroborate the effectiveness and safety of Botulinum toxin treatment, with large-scale studies indicating symptom control lasts, on average, around 15 weeks. |
| first_indexed | 2024-03-10T23:47:43Z |
| format | Article |
| id | doaj.art-9424c2feb86f430695dc2197ed7d39a9 |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-10T23:47:43Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-9424c2feb86f430695dc2197ed7d39a92023-11-19T01:55:17ZengMDPI AGLife2075-17292023-08-01138176010.3390/life13081760Clinical Application of Botulinum Toxin for Hemifacial SpasmChang-Kyu Park0Seung-Hoon Lim1Kwan Park2Department of Neurosurgery, Kyung Hee University College of Medicine, Seoul 02447, Republic of KoreaDepartment of Neurosurgery, Kyung Hee University College of Medicine, Seoul 02447, Republic of KoreaDepartment of Neurosurgery, Konkuk University Medical Center, Seoul 05030, Republic of KoreaHemifacial spasm is typically caused by contact between the facial nerve and blood vessels. Microvascular decompression, a treatment that directly addresses this pathogenesis, is often considered the most effective treatment method. However, surgery is not immediately performed for patients at risk from the surgical treatment, or for those with an unclear diagnosis. In these instances, Botulinum toxin injection can help manage the patient’s symptoms. Numerous studies corroborate the effectiveness and safety of Botulinum toxin treatment, with large-scale studies indicating symptom control lasts, on average, around 15 weeks.https://www.mdpi.com/2075-1729/13/8/1760hemifacial spasmbotulinum toxin |
| spellingShingle | Chang-Kyu Park Seung-Hoon Lim Kwan Park Clinical Application of Botulinum Toxin for Hemifacial Spasm Life hemifacial spasm botulinum toxin |
| title | Clinical Application of Botulinum Toxin for Hemifacial Spasm |
| title_full | Clinical Application of Botulinum Toxin for Hemifacial Spasm |
| title_fullStr | Clinical Application of Botulinum Toxin for Hemifacial Spasm |
| title_full_unstemmed | Clinical Application of Botulinum Toxin for Hemifacial Spasm |
| title_short | Clinical Application of Botulinum Toxin for Hemifacial Spasm |
| title_sort | clinical application of botulinum toxin for hemifacial spasm |
| topic | hemifacial spasm botulinum toxin |
| url | https://www.mdpi.com/2075-1729/13/8/1760 |
| work_keys_str_mv | AT changkyupark clinicalapplicationofbotulinumtoxinforhemifacialspasm AT seunghoonlim clinicalapplicationofbotulinumtoxinforhemifacialspasm AT kwanpark clinicalapplicationofbotulinumtoxinforhemifacialspasm |